Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Saved in:
| Title: | Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension. |
|---|---|
| Authors: | Adams D; Department of Neurology, Centre Hospitalo Universitaire Bicêtre, Assistance Publique Hopitaux de Paris, Université Paris-Saclay, L'Institut national de la santé et de la recherche médicale U-1195, Le Kremlin Bicêtre Cedex, France., Wixner J; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Polydefkis M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Berk JL; Boston University School of Medicine, Boston, Massachusetts., Conceição IM; Department of Neurosciences and Mental Health, Unidade Local De Saúde Santa Maria, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.; Instituto de Fisiologia, Instituto de Medicina Molecular, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Peltier A; Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee., Ueda M; Department of Neurology, Kumamoto University Hospital, Kumamoto, Japan., Bender S; Alnylam Pharmaceuticals, Cambridge, Massachusetts., Capocelli K; Alnylam Pharmaceuticals, Cambridge, Massachusetts., Jay PY; Alnylam Pharmaceuticals, Cambridge, Massachusetts., Yureneva E; Alnylam Pharmaceuticals, Cambridge, Massachusetts., Obici L; Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy. |
| Corporate Authors: | patisiran Global OLE study group |
| Source: | JAMA neurology [JAMA Neurol] 2025 Mar 01; Vol. 82 (3), pp. 228-236. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39804640 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Adams+D%22">Adams D</searchLink>; Department of Neurology, Centre Hospitalo Universitaire Bicêtre, Assistance Publique Hopitaux de Paris, Université Paris-Saclay, L'Institut national de la santé et de la recherche médicale U-1195, Le Kremlin Bicêtre Cedex, France.<br /><searchLink fieldCode="AU" term="%22Wixner+J%22">Wixner J</searchLink>; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Polydefkis+M%22">Polydefkis M</searchLink>; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Berk+JL%22">Berk JL</searchLink>; Boston University School of Medicine, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Conceição+IM%22">Conceição IM</searchLink>; Department of Neurosciences and Mental Health, Unidade Local De Saúde Santa Maria, Hospital de Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.; Instituto de Fisiologia, Instituto de Medicina Molecular, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Dispenzieri+A%22">Dispenzieri A</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Peltier+A%22">Peltier A</searchLink>; Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Ueda+M%22">Ueda M</searchLink>; Department of Neurology, Kumamoto University Hospital, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Bender+S%22">Bender S</searchLink>; Alnylam Pharmaceuticals, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Capocelli+K%22">Capocelli K</searchLink>; Alnylam Pharmaceuticals, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Jay+PY%22">Jay PY</searchLink>; Alnylam Pharmaceuticals, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Yureneva+E%22">Yureneva E</searchLink>; Alnylam Pharmaceuticals, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Obici+L%22">Obici L</searchLink>; Amyloidosis Research and Treatment Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22patisiran+Global+OLE+study+group%22">patisiran Global OLE study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101589536%22">JAMA neurology</searchLink> [JAMA Neurol] 2025 Mar 01; Vol. 82 (3), pp. 228-236. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589536 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686149%22">21686149 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Neurol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39804640 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaneurol.2024.4631 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 228 Titles: – TitleFull: Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Adams D – PersonEntity: Name: NameFull: Wixner J – PersonEntity: Name: NameFull: Polydefkis M – PersonEntity: Name: NameFull: Berk JL – PersonEntity: Name: NameFull: Conceição IM – PersonEntity: Name: NameFull: Dispenzieri A – PersonEntity: Name: NameFull: Peltier A – PersonEntity: Name: NameFull: Ueda M – PersonEntity: Name: NameFull: Bender S – PersonEntity: Name: NameFull: Capocelli K – PersonEntity: Name: NameFull: Jay PY – PersonEntity: Name: NameFull: Yureneva E – PersonEntity: Name: NameFull: Obici L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2168-6157 Numbering: – Type: volume Value: 82 – Type: issue Value: 3 Titles: – TitleFull: JAMA neurology Type: main |
| ResultId | 1 |